TY - JOUR
T1 - MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis
AU - Bousquet, Jean
AU - Schünemann, Holger J.
AU - Hellings, Peter W.
AU - Arnavielhe, Sylvie
AU - Bachert, Claus
AU - Bedbrook, Anna
AU - Bergmann, Karl-Christian
AU - Bosnic-Anticevich, Sinthia
AU - Brozek, Jan
AU - Calderon, Moises
AU - Canonica, G. Walter
AU - Casale, Thomas B.
AU - Chavannes, Niels H.
AU - Cox, Linda
AU - Chrystyn, Henry
AU - Cruz, Alvaro A.
AU - Dahl, Ronald
AU - de Carlo, Giuseppe
AU - Demoly, Pascal
AU - Devillier, Phillipe
AU - Dray, Gérard
AU - Fletcher, Monica
AU - Fokkens, Wytske J.
AU - Fonseca, Joao
AU - Gonzalez-Diaz, Sandra N.
AU - Grouse, Lawrence
AU - Keil, Thomas
AU - Kuna, Piotr
AU - Larenas-Linnemann, Désirée
AU - Lodrup Carlsen, Karin C.
AU - Meltzer, Eli O.
AU - Mullol, Jaoquim
AU - Muraro, Antonella
AU - Naclerio, Robert N.
AU - Palkonen, Susanna
AU - Papadopoulos, Nikolaos G.
AU - Passalacqua, Giovanni
AU - Price, David
AU - Ryan, Dermot
AU - Samolinski, Boleslaw
AU - Scadding, Glenis K.
AU - Sheikh, Aziz
AU - Spertini, François
AU - Valiulis, Arunas
AU - Valovirta, Erkka
AU - Walker, Samantha
AU - Wickman, Magnus
AU - Yorgancioglu, Arzu
AU - Haahtela, Tari
AU - AUTHOR GROUP
AU - Bel, Elisabeth H.
PY - 2016
Y1 - 2016
N2 - The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment adjustment is required. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control. CDSSs should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine treatment and its step-up or step-down strategy depending on AR control. Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR [fighting chronic diseases for active and healthy ageing]), one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (the MACVIA-ARIA Sentinel Network). A CDSS is currently being developed to optimize AR control. An algorithm developed by consensus is presented in this article. This algorithm should be confirmed by appropriate trials
AB - The selection of pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, prominent symptoms, symptom severity, control of AR, patient preferences, and cost. Allergen exposure and the resulting symptoms vary, and treatment adjustment is required. Clinical decision support systems (CDSSs) might be beneficial for the assessment of disease control. CDSSs should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine treatment and its step-up or step-down strategy depending on AR control. Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon (MACVIA-LR [fighting chronic diseases for active and healthy ageing]), one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (the MACVIA-ARIA Sentinel Network). A CDSS is currently being developed to optimize AR control. An algorithm developed by consensus is presented in this article. This algorithm should be confirmed by appropriate trials
U2 - https://doi.org/10.1016/j.jaci.2016.03.025
DO - https://doi.org/10.1016/j.jaci.2016.03.025
M3 - Article
C2 - 27260321
SN - 0091-6749
VL - 138
SP - 367-374.e2
JO - Journal of allergy and clinical immunology
JF - Journal of allergy and clinical immunology
IS - 2
ER -